
DiNAQOR is a global gene therapy platform company focused on advancing novel solutions for patients suffering from heart disease. We are headquartered in Pfäffikon, Switzerland, with additional presence in London, England and Boston, Massachusetts.
Location: Switzerland, Zurich, Pfäffikon
Employees: 11-50
Founded date: 2019
Mentions in press and media 12
Date | Title | Description |
31.05.2024 | Swiss life science startups headed for San Diego | The BIO International Convention 2024, taking place in San Diego from 3 to 6 June, is the largest global biotechnology event with over 20,000 industry leaders from around the world attending. The target group includes representatives from ... |
22.05.2024 | "EMBRACING INTERNATIONAL ALLIANCES" SWISS BIOTECH INNOVATION ON DISPLAY AT THE BIO 2024 INTERNATIONAL CONVENTION IN SAN DIEGO JUNE 3-6, 2024 | ZURICH, May 22, 2024 /PRNewswire/ -- Swiss life science innovation will again be on display at the BIO 2024 convention in San Diego. Switzerland Global Enterprise will present 41 leading Swiss biotech stars at the SWISS BIOTECH pavilion dem... |
05.05.2023 | DINAQOR verkauft Tochterunternehmen an Siegfried | |
13.01.2023 | Seasoned executives to drive startups in the next phase | |
20.07.2021 | Startups welcome legendary board members aboard | DiNAQor – three prominent cardiovascular industry and Academic Experts Louis G. Lange, Steven Zelenkofske, and Silke Rickert-Sperling, some of the most renowned cardiovascular industry and academic experts are joining the board of directors... |
01.07.2021 | DiNAQOR Expands Board of Directors with Three Renowned Cardiovascular Industry and Academic Experts | |
22.01.2021 | DiNAQOR acquires Germany-based company | Founded in 2019 by several leading pharmaceutical and biotechnology executives and academics with deep cardiology and gene therapy expertise, DiNAQOR is focused on developing gene therapies for the heart. The company's lead preclinical prog... |
22.01.2021 | DiNAQOR acquires Germany-based company | |
25.11.2020 | Internationalising with new leaders | |
25.11.2020 | Internationalising with new leaders | Tomahawk.VC invests in teams and founders with a 'global-first' approach. Since its launch in April 2020, the firm has concluded four investments across B2B SaaS and Decentralized Finance with teams in Germany and Switzerland. To further su... |
Show more